Neuraxpharm is a European specialty pharmaceutical company. With over 35 years of experience, they focus on the treatment of central nervous system disorders and claim to have a direct presence in 20 European countries. The company's portfolio includes more than 120 molecules for the treatment of Depression, Anxiety, Parkinson's, Alzheimer's, Epilepsy, Schizophrenia/Psychosis, and other central nervous system disorders. Neuraxpharm has a manufacturing facility for Finished Dosage Forms in Spain. They are also involved in medical devices and digital health, with a focus on innovation and R&D.
Headquarters
Ul. Poleczki 35
Warsaw; Mazowieckie;
Postal Code: 02-822
Contact Details: Purchase the Neuraxpharm Polska Sp. z o.o. report to view the information.
Website: http://www.neuraxpharm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service